Kristen Galfetti
Net worth: 1 495 $ as of 2024-04-29
Profile
Kristen Galfetti formerly worked at Genzyme Corp., as Director-Investor Relations, Sanofi, as Senior Director-Investor Relations, National Investor Relations Institute, as Director, AMAG Pharmaceuticals, Inc., as Senior Director-Investor Relations, Cynapsus Therapeutics, Inc., as VP-Investor Relations & Corporate Communications, and Titan Medical, Inc., as VP-Investor Relations & Corporate Communications from 2021 to 2023.
Ms. Galfetti received her Masters Business Admin degree from Bentley University and undergraduate degree from the University of Vermont.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
TITAN MEDICAL INC.
0.03% | 2022-12-15 | 36,454 ( 0.03% ) | 1 495 $ | 2024-04-29 |
Former positions of Kristen Galfetti
Companies | Position | End |
---|---|---|
TITAN MEDICAL INC. | Investor Relations Contact | 2023-02-07 |
SANOFI | Investor Relations Contact | 1910-01-01 |
CYNAPSUS THERAPEUTICS INC | Investor Relations Contact | - |
AMAG PHARMACEUTICALS, INC. | Public Communications Contact | - |
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Director/Board Member | - |
Training of Kristen Galfetti
Bentley University | Masters Business Admin |
University of Vermont | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
TITAN MEDICAL INC. | Health Technology |
SANOFI | Health Technology |
Private companies | 4 |
---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Commercial Services |
AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
Cynapsus Therapeutics, Inc.
Cynapsus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cynapsus Therapeutics, Inc. operated as a pharmaceutical company, which developed an improved dosing formulation of an approved drug used to treat the symptoms of Parkinson's disease. The company was founded by Andrew Williams and David Hill on January 16, 2004 and was headquartered in Toronto, Canada. | Health Technology |
- Stock Market
- Insiders
- Kristen Galfetti